Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

441 questions · 461 findings · 48 reviews

No studies found 76 · 16.5%GRADE not reported 94 · 20.4%Very low 82 · 17.8%Low 119 · 25.8%Moderate 73 · 15.8%High 17 · 3.7%

Flunarizine vs placebo

Death or dependency at end of · people with acute ischemic stroke

Flunarizine showed no clear difference in death or dependency at end of compared with placebo (low certainty).

1 finding from 1 review

Flunarizine vs placebo

Death at the end of treatment · people with acute ischemic stroke

Flunarizine showed no clear difference in death at the end of treatment compared with placebo (low certainty).

1 finding from 1 review

Flunarizine vs placebo

Recurrence of stroke at the end of · people with acute ischemic stroke

Flunarizine showed no clear difference in recurrence of stroke at the end of compared with placebo (low certainty).

1 finding from 1 review

Flunarizine vs placebo

Adverse events during treatment period · people with acute ischemic stroke

Flunarizine may leads to higher adverse events during treatment period compared with placebo (low certainty).

1 finding from 1 review

Isradipine vs placebo

Death or dependency at end of · people with acute ischemic stroke

Isradipine showed no clear difference in death or dependency at end of compared with placebo (low certainty).

1 finding from 1 review

Isradipine vs placebo

Death at the end of · people with acute ischemic stroke

Isradipine showed no clear difference in death at the end of compared with placebo (low certainty).

1 finding from 1 review

Nimodipine vs placebo

Death or dependency at end of · people with acute ischemic stroke

Nimodipine showed no clear difference in death or dependency at end of compared with placebo (moderate certainty).

1 finding from 1 review

Nimodipine vs placebo

Death at the end of treatment · people with acute ischemic stroke

Nimodipine showed no clear difference in death at the end of treatment compared with placebo (moderate certainty).

1 finding from 1 review

Intervention not reported

Tardive dyskinesia ‐ not improved to a clinically important extent · people with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether the intervention changes tardive dyskinesia ‐ not improved to a clinically important extent (very low certainty).

1 finding from 1 review

Intervention not reported

Tardive dyskinesia ‐ deterioration · people with antipsychotic‐induced tardive dyskinesia

The review found no eligible studies for this question.

1 finding from 1 review

Intervention not reported

Adverse effects ‐ important extrapyramidal adverse effects · people with antipsychotic‐induced tardive dyskinesia

The review found no eligible studies for this question.

1 finding from 1 review